Top Pharmaceuticals companies in Denmark by Shareholders' Equity

This ranking features the top 15 Pharmaceuticals companies in Denmark ranked by Shareholders' Equity, totalling a Shareholders' Equity of USD 31.73 B, for January 15, 2025.
#
Name
Shareholders' Equity
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 15.77 B
Dec. 31, 2023 USD 81.56 -2.90%

Denmark

2
USD 4.68 B
Dec. 31, 2023 USD 216.88 1.28%

Denmark

3
USD 3.26 B
Dec. 31, 2023 USD 5.46 0.56%

Denmark

4
USD 2.68 B
Sept. 30, 2024 USD 109.06 -0.12%

Denmark

5
USD 2.07 B
Dec. 31, 2023 USD 54.16 -1.39%

Denmark

6
USD 1.53 B
Dec. 31, 2023 USD 26.62 -0.36%

Denmark

7
USD 834.79 M
Sept. 30, 2024 USD 18.73 1.26%

Denmark

8
USD 658.24 M
Dec. 31, 2023 USD 20.15 -0.78%

Denmark

9
USD 235.77 M
Dec. 31, 2023 USD 95.84 0.08%

Denmark

10
USD 81.40 M
June 30, 2024 USD 70.50 0.61%

Denmark

11
USD 71.00 M
Dec. 31, 2023 USD 91.43 -1.85%

Denmark

12
USD 8.90 M
Dec. 31, 2023 USD 0.20 -2.77%

Denmark

13
USD 6.45 M
Dec. 31, 2023 USD 2.17 5.88%

Denmark

14
USD -2.17 M
Dec. 31, 2023 USD 0.57 1.47%

Denmark

15
USD -160.81 M
Dec. 31, 2023 USD 131.57 -1.84%

Denmark

Frequently Asked Questions
  • Which Pharmaceuticals company in Denmark has the highest Shareholders' Equity ?

    The Pharmaceuticals company in Denmark with the highest Shareholders' Equity is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 15.77 B.

  • Which Pharmaceuticals company in Denmark has the lowest Shareholders' Equity ?

    The Pharmaceuticals company in Denmark with the lowest Shareholders' Equity is Ascendis Pharma A/S (NasdaqGS: ASND) at USD -160.81 M.